BIO Gross Margin Analysis
Higher than 23% of Healthcare sector peers
Updated 36h ago·SEC filings & market data
Key Takeaway
Bio-Rad's gross margin of 52.3% means that for every dollar of revenue, the company keeps about 52 cents after paying the direct costs of producing its goods or services, with the rest covering other expenses.
Sector Performance
23th percentileBIO
52.3%
Sector Median
69.8%
Sector Avg
-24.1%
Prior Period
49.8%(Apr 2026)
Deep Analysis
Bio-Rad's gross margin of 52.3% means that for every dollar of revenue, the company keeps about 52 cents after paying the direct costs of producing its goods or services, with the rest covering other expenses.
This figure sits well below the healthcare sector median of 69.8%, placing Bio-Rad at the 23rd percentile among its peers—meaning 77% of comparable companies report higher gross margins. Because only a single historical data point (52.3%) is provided, there is no year-over-year change, quarter-over-quarter change, or multi-quarter trend direction to evaluate. The combination of a below-median gross margin and an absent trend makes it impossible to determine if the company's cost structure is improving or deteriorating, which adds uncertainty for investors. This metric neither supports nor contradicts the overall NEUTRAL verdict; the low margin highlights a competitive disadvantage in profitability from sales, but without any movement over time, it does not signal a clear reason to upgrade or downgrade the stock.
Frequently Asked Questions
What does the Gross Margin tell investors about BIO?
Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.
How is the Gross Margin calculated?
Gross Margin is calculated as: Gross Profit / Revenue.
How does BIO's Gross Margin compare to its sector?
BIO's Gross Margin of 52.3% compares to a Healthcare sector median of 69.8%, placing it in the 23th percentile.
Who are BIO's closest peers by Gross Margin?
The closest Healthcare peers by Gross Margin include: BSX (69.4%), BMY (70.2%), TDOC (67.8%), ZBH (72.4%), TECH (66.9%).
Learn More About Gross Margin
The Formula
Gross Profit / Revenue
Why It Matters
Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.
Master BIO's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full BIO research report →BIO
52.3%
Sector Median
69.8%
Sector Avg
-24.1%
How BIO's Gross Margin compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.